Mr. Gill is the CEO of Ohm Oncology, California, a company that specializes in oncology and neoplasms by developing novel drugs for the management of treatment - refractory and difficult to treat cancers.
Mr. Gill did his B.Tech in Electrical Engineering from IIT Kanpur in 1969. He earned an M.S from University of Nebraska and an MBA from University of Western Ontario, Canada. Earlier, Mr. Gill was VP and General Manager of Kodak’s Interactive Systems, VP of Finance at TRW-Fujitsu and Director of business development at VisiCorp.He is past CEO and President of Nektar Therapeutics and has witnessed the company's growth from a private start-up to a public company with 800 employees and a market cap of over $2 billion USD. He is also currently serving as an advisor for several health care companies in India.
